Incyte Corp (NASDAQ:INCY)

81.21
Delayed Data
As of Sep 20
 +3.09 / +3.96%
Today’s Change
57.00
Today|||52-Week Range
89.30
+27.71%
Year-to-Date

Today’s Trading

Previous close78.12
Today’s open78.52
Day’s range78.37 - 81.64
Volume2,206,030
Average volume (3 months)1,191,922
Market cap$16.4B
Data as of 4:00pm ET, 09/20/2019

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+222.92%
Earnings growth (next 5 years)+41.50%
Revenue growth (last year)+22.50%
P/E ratio57.2
Price/Sales7.29
Price/Book8.47

Competitors

 Today’s
change
Today’s
% change
SGENSeattle Genetics Inc+1.23+1.69%
MYLMylan NV0.000.00%
ALXNAlexion Pharmaceutic...+0.65+0.62%
ALNYAlnylam Pharmaceutic...+1.90+2.25%
Data as of 4:00pm ET, 09/20/2019

Financials

Next reporting dateOctober 30, 2019
EPS forecast (this quarter)$0.41
Annual revenue (last year)$1.9B
Annual profit (last year)$109.5M
Net profit margin5.82%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
Christiana Stamoulis
Corporate headquarters
Wilmington, Delaware

Forecasts